Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

VKTX RSS Feed
Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: DMOST, greens12
Search This Board: 
Last Post: 5/14/2019 3:12:13 PM - Followers: 80 - Board type: Free - Posts Today: 0

 
Novel therapeutics for metabolic<Br/>and endocrine disorders
  1. 2
    2
    2
     
 

VK0612

Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.
 

Overview

Pills

We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

VKTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Current Report Filing (8-k) 05/23/2019 04:48:16 PM
VKTX News: Quarterly Report (10-q) 05/02/2019 05:12:42 PM
VKTX News: Current Report Filing (8-k) 05/02/2019 04:08:07 PM
VKTX News: Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update 05/02/2019 04:05:00 PM
VKTX News: Viking Therapeutics to Participate in Upcoming Investor Conferences 04/30/2019 07:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1790   GO VKTX DMOST 05/14/19 03:12:13 PM
#1789   Have Insiders Been Buying Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares? DMOST 05/14/19 03:09:42 PM
#1788   Dreaming! sorkin 05/08/19 06:13:36 AM
#1787   GILD or BMY or PFE will offer to guyguyguy 05/06/19 09:19:31 PM
#1786   28.7 million shares short!! sorkin 04/30/19 01:16:40 PM
#1785   Wow! Excellent analysis. I am intrigued. Sage7243 04/27/19 10:49:38 PM
#1784   That means absolutely nothing for the most part, Murph32 04/26/19 06:07:52 AM
#1783   VRTX needs another dosing 40mg/day in their trial! sorkin 04/24/19 11:54:34 AM
#1782   Largest institutional holder Fidelity management and research Sold sorkin 04/24/19 11:31:41 AM
#1781   All the Analysts covering this stock have Targets greens12 04/16/19 11:22:53 AM
#1780   $5 sorkin 04/15/19 01:09:10 PM
#1779   What Are Analysts Recommending for VKTX and ENTA? DMOST 04/15/19 09:22:20 AM
#1778   * * $VKTX Video Chart 04-12-2019 * * ClayTrader 04/12/19 05:22:10 PM
#1777   Sell the news and cashin sorkin 04/11/19 09:18:10 AM
#1776   Compared to Placebo, Absolute liver fat reduction with sorkin 04/11/19 09:16:55 AM
#1775   <This stock will be < $2 in 2-3 years> girlfriend 04/11/19 08:45:41 AM
#1774   Ha ha ha ha! Good one. Natureboy1 04/11/19 08:40:38 AM
#1773   This stock will be < $2 in 2-3 sorkin 04/11/19 08:27:54 AM
#1772   Viking Therapeutics Presents New Data from Phase 2 Paullee 04/11/19 07:27:41 AM
#1771   Why Viking Therapeutics Stock Perked Up in March DMOST 04/09/19 06:22:56 AM
#1770   Here's Why Investors Are Betting Against These 2 DMOST 04/09/19 06:17:12 AM
#1769   It should move up to 13.00 fairly quickly greens12 04/07/19 08:07:08 PM
#1768   What’s your timeline for $18 once it breaks Natureboy1 04/07/19 05:55:39 PM
#1767   Break the 200dma around 10.80 and we should greens12 04/07/19 03:42:31 PM
#1766   Viking Therapeutics to Present New Data from Phase DMOST 04/04/19 08:24:57 AM
#1765   Nice run recently. Good to see. I had mauiguy2 04/03/19 01:39:07 AM
#1764   Here's What Pushed Viking Therapeutics Higher on Friday DMOST 04/01/19 12:24:22 AM
#1763   VKTX ....Great! We'll accept the positive moves up anyway we DMOST 03/30/19 05:14:30 AM
#1762   SVB Leerink upgraded VKTX from Market Perform to greens12 03/30/19 12:36:06 AM
#1761   * * $VKTX Video Chart 03-29-2019 * * ClayTrader 03/29/19 05:41:56 PM
#1760   VKTX ....On a Friday no less. DMOST 03/29/19 01:10:38 PM
#1759   Almost 8 million shares alittle more than halfway girlfriend 03/29/19 01:01:28 PM
#1758   VKTX ....yes sir. DMOST 03/29/19 12:45:42 PM
#1757   Getting a nice lift up today ..,, greens12 03/29/19 10:19:05 AM
#1756   Analysts Are Mostly Positive on Viking Therapeutics in March DMOST 03/27/19 11:17:01 PM
#1755   Anyone know when the P3 data is scheduled The Canes 03/27/19 09:04:17 AM
#1754   Wow... premarket. Just went bye 9.76!!!!!!!!!!!!!!!!!! now invest 03/27/19 07:31:58 AM
#1753   Well premarket VKTX is over $9.00!!!thinking shorts are now invest 03/27/19 07:27:40 AM
#1752   Yes they are nuts, stock is almost trading greens12 03/26/19 10:27:28 AM
#1751   RJ has 40 dollar plus price target. jdlamont 03/25/19 01:37:58 PM
#1750   Schedule of events and goals for the remaining Fress 03/22/19 08:48:03 PM
#1749   VKTX presentation-slideshow https://seekingalpha.com/article/4250344-viking-ther greens12 03/21/19 07:14:43 PM
#1748   current market cap around 600 mil. jdlamont 03/20/19 12:25:40 AM
#1746   VKTX ...They could buy back some of the shares DMOST 03/18/19 12:50:00 PM
#1745   Don't forget LGND just raised $800 mil, WHY? jdlamont 03/18/19 12:12:47 PM
#1744   VKTX .....Many agree. DMOST 03/17/19 06:25:08 PM
#1743   I still wish they would have done a greens12 03/17/19 12:07:05 AM
#1742   Edited Transcript of VKTX earnings conference call or DMOST 03/16/19 02:13:07 AM
#1741   VKTX: Phase 2b Trial for VK2809 to Initiate 2H19… DMOST 03/15/19 05:00:52 AM
#1739   Brian is not going to give away the greens12 03/07/19 06:43:37 PM
PostSubject